​

Funding Round

Series A - mybacs

Series A - mybacs

Investment Firm

Overview

mybacs is a Biotechnology company specialized in the human microbiome.

Announced Date

Oct 19, 2023

Funding Type

Series A

Highlights

Location

Zug, Switzerland, Europe

Social

Investor Lead

naturalX Health Ventures

naturalX Health Ventures

naturalX Health Ventures is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

5

Investor Name
Participant InvestornaturalX Health Ventures
Participant InvestorSevenVentures
Participant InvestorWENVEST Capital
Participant InvestorJoyance Partners
Participant InvestorGlobal Founders Capital

Round Details and Background

mybacs raised $5900000 on 2023-10-19 in Series A

mybacs is a Biotechnology company specialized in the human microbiome.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Aug 29, 2019
Pre Seed Round - mybacs
1-778.0K
Jul 13, 2020
Seed Round - mybacs
3-960.0K
Oct 19, 2023
Series A - mybacs
5-5.9M

Recent Activity

There is no recent news or activity for this profile.